Understanding cardiovascular risks in endometriosis patients

Endometriosis increases the risk of cardiovascular events.

PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale | Psychedelic Finance

Oxford, Ohio and Denver, Colorado–(Newsfile Corp. – July 21, 2023) – PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (“PsyBio” or the “Company“), an intellectual property

July 21, 2023

HF-158K1 by HighField Biopharmaceuticals for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast

July 6, 2024

US CDC AdCom recommends lowering the age for pneumococcal vaccines

The CDC AdCom recommended for pneumococcal vaccination in all adults older than 50 years and in 19–49 year olds with certain underlying conditions, risk factors

October 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.